< Back to Article

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Table 1

Baseline characteristics of the melatonin and carvedilol use groups from the COVID-19 registry.

doi: https://doi.org/10.1371/journal.pbio.3000970.t001